Bausch + Lomb Future Growth
Future criteria checks 4/6
Bausch + Lomb is forecast to grow earnings and revenue by 72.6% and 5.6% per annum respectively. EPS is expected to grow by 75% per annum. Return on equity is forecast to be 6% in 3 years.
Key information
72.6%
Earnings growth rate
75.0%
EPS growth rate
| Medical Equipment earnings growth | 16.2% |
| Revenue growth rate | 5.6% |
| Future return on equity | 6.0% |
| Analyst coverage | Good |
| Last updated | 23 Sep 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 5,327 | 110 | 669 | 793 | 10 |
| 12/31/2025 | 5,055 | -52 | 496 | 661 | 15 |
| 12/31/2024 | 4,750 | -347 | 193 | 437 | 15 |
| 6/30/2024 | 4,495 | -456 | -137 | 119 | N/A |
| 3/31/2024 | 4,314 | -337 | -131 | 80 | N/A |
| 12/31/2023 | 4,146 | -260 | -198 | -17 | N/A |
| 9/30/2023 | 3,969 | -207 | -17 | 127 | N/A |
| 6/30/2023 | 3,904 | -141 | -57 | 106 | N/A |
| 3/31/2023 | 3,810 | -104 | 116 | 286 | N/A |
| 12/31/2022 | 3,768 | 6 | 170 | 345 | N/A |
| 9/30/2022 | 3,773 | 58 | 144 | 348 | N/A |
| 6/30/2022 | 3,780 | 136 | 398 | 594 | N/A |
| 3/31/2022 | 3,773 | 175 | 482 | 688 | N/A |
| 12/31/2021 | 3,765 | 182 | 680 | 873 | N/A |
| 9/30/2021 | 3,708 | -78 | 636 | 845 | N/A |
| 6/30/2021 | 3,675 | -53 | 539 | 776 | N/A |
| 3/31/2021 | 3,517 | -44 | 370 | 618 | N/A |
| 12/31/2020 | 3,412 | -18 | 263 | 522 | N/A |
| 12/31/2019 | 3,778 | 298 | 619 | 799 | N/A |
| 12/31/2018 | 3,665 | 710 | 662 | 763 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: S2L is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.8%).
Earnings vs Market: S2L is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: S2L is expected to become profitable in the next 3 years.
Revenue vs Market: S2L's revenue (5.6% per year) is forecast to grow faster than the German market (5.5% per year).
High Growth Revenue: S2L's revenue (5.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: S2L's Return on Equity is forecast to be low in 3 years time (6%).